Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00060632
Status:
COMPLETED
Last Update Posted:
2015-08-27
First Post:
2003-05-08
Brief Title:
Safety Study of Ridaforolimus in Patients With Advanced Refractory or Recurrent Malignancies MK-8669-001 AM5COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-04
Start Date Type:
None
Primary Completion Date:
2005-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-10
Completion Date Type:
ACTUAL
First Submit Date:
2003-05-08
First Submit QC Date:
May 9 2003
Study First Post Date:
2003-05-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-08-26
Last Update Post Date:
2015-08-27
Last Update Post Date Type:
ESTIMATED